Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;24(14):1677-1685.
doi: 10.2174/1871530322666220811103755.

Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the First Waves of COVID-19 in North-East Italy

Affiliations

Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the First Waves of COVID-19 in North-East Italy

Chiara Sabbadin et al. Endocr Metab Immune Disord Drug Targets. 2024.

Abstract

Objective: COVID-19 is a potentially serious new infection first reported in North East Italy in Spring, 2020. Patients with adrenal insufficiency (AI) have a known increased risk of infections that could precipitate to adrenal crisis. Even COVID-19-related psycho-social impact could affect their health, requiring a dynamic adaptation of daily glucocorticoid (GC) therapy. The aim of this study was to evaluate the incidence of COVID-19 infection and self-reported outcomes in AI patients after the first pandemic waves.

Methods: It was an open-label, cross-sectional monocentric study on 84 (65 primary, 19 secondary) AI patients resident in Veneto and followed-up in our clinical Endocrine Unit. All patients underwent serological investigation of anti-SARS-CoV2 IgG, answered the purpose-built "ADDICOVID" questionnaire in August, 2020, and were re-contacted to reevaluate COVID-19 infection occurrence in March-April, 2021.

Results: All patients resulted negative to the serological test for anti-SARS-CoV2 IgG at the end of the first pandemic wave. After the third wave, COVID-19 infection occurred in 8 patients without the need for hospitalization. Half patients felt an increased risk of COVID-19 infection, significantly associated with increased stress and GC stress dose. Only one patient reported stress-correlated adrenal crisis. The majority of AI workers changed working habits, significantly reducing COVID- 19-related stress.

Conclusion: AI patients did not show an increased incidence of COVID-19, but the perception of increased COVID-19 infection risk significantly impacted their psychological well-being, working habits, and GC daily doses. Therapeutic patient education is crucial, especially for AI workers, to prevent and treat situations that could lead to an adrenal crisis.

Keywords: Adrenal insufficiency; COVID-19; IgG anti-SARS-CoV-2; cortisol response.; glucocorticoid therapy; stress.

PubMed Disclaimer

References

    1. Bornstein S.R.; Allolio B.; Arlt W.; Barthel A.; Don-Wauchope A.; Hammer G.D.; Husebye E.S.; Merke D.P.; Murad M.H.; Stratakis C.A.; Torpy D.J.; Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016,101(2),364-389 - DOI - PubMed
    1. Betterle C.; Presotto F.; Furmaniak J.; Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J Endocrinol Invest 2019,42(12),1407-1433 - DOI - PubMed
    1. Ceccato F.; Scaroni C.; Central adrenal insufficiency: Open issues regarding diagnosis and glucocorticoid treatment. Clin Chem Lab Med 2019,57(8),1125-1135 - DOI - PubMed
    1. Allolio B.; Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015,172(3),R115-R124 - DOI - PubMed
    1. Hahner S.; Spinnler C.; Fassnacht M.; Burger-Stritt S.; Lang K.; Milovanovic D.; Beuschlein F.; Willenberg H.S.; Quinkler M.; Allolio B.; High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: A prospective study. J Clin Endocrinol Metab 2015,100(2),407-416 - DOI - PubMed

LinkOut - more resources